临床与影像学特征能否帮助预测无上皮异型性的B3乳腺病变(B3a)的恶性风险?
研究评估了153例影像引导下空心针活检诊断为B3a乳腺病变(74例乳头状瘤、51例放射状瘢痕、28例纤维上皮病变)手术切除后的组织学结果,11例(7%)升级为恶性,均为非高级别导管原位癌。病变大小>10 mm(OR=9.3832)和BI-RADS 4-5类(OR=12.6004)是升级为恶性的独立预测因素。
要点
- B3a病变切除后恶性升级率低(11/153,7%),均为非高级别导管原位癌。
- 病变大小>10 mm和BI-RADS 4-5类是升级为恶性的独立预测因素。
- 活检后无残留微钙化与恶性风险降低相关(15/16[93.7%];p=0.0297)。
核心结论
- B3a病变切除后恶性风险低;病变大小>10 mm和BI-RADS 4-5类可能是有用的恶性升级预测因素。
研究设计与样本
- 评估153例影像引导下空心针活检诊断为B3a的乳腺病变(74例乳头状瘤、51例放射状瘢痕、28例纤维上皮病变),均行手术切除;评估所有B3a病变及亚类的恶性阳性预测值(PPV),多变量分析临床特征(年龄、乳腺癌家族史或个人史、症状)、诊断发现(影像方法、病变大小、最终BI-RADS分类)与最终切除结果的相关性。
诊断标准与关键数值
- 全部B3a病变切除后恶性升级11/153(7%),均为非高级别导管原位癌。
- 仅乳腺X线发现的病变升级3/21(14%),乳腺X线和超声均发现的病变升级7/44(16%)。
- 病变大小>10 mm升级10/74(13.5%),BI-RADS 4-5类升级8/29(27.6%)。
- 活检后无残留微钙化与恶性风险降低相关(15/16[93.7%];p=0.0297)。
- 病变大小>10 mm(OR=9.3832;95%;p=0.0398)和BI-RADS 4-5类(OR=12.6004;95%;p=0.0006)是升级为恶性的独立预测因素。
临床应用与阅片要点
- 对于影像引导下空心针活检诊断为B3a的病变,病变大小>10 mm和BI-RADS 4-5类可能提示升级为恶性的风险较高。
- 活检后无残留微钙化可能与恶性风险降低相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate excision histology outcome of B3a lesions diagnosed at imaging-guided core biopsy and assess whether clinical and radiologic features may predict upgrade to malignancy.
METHODS: A total of 153 B3a lesions (74 papillomas, 51 radial scars and 28 fibro-epithelial lesions) that underwent surgical excision were assessed. PPV for malignancy in all B3a lesions and specific for each sub-category was evaluated. Multivariate analysis was conducted to identify association between clinical (age, family or personal history of breast cancer, symptoms), diagnostic findings (imaging modality, lesion size, final BI-RADS category) and final excision outcome.
RESULTS: Eleven (7%) of 153 B3a lesions were upgraded to malignancy. All carcinomas diagnosed on excision were non-high grade DCIS. Following features were significantly associated with malignancy: lesions identified only on mammography (3/21; 14%), both mammography and ultrasound (7/44; 16%), lesion size > 10 mm (10/74; 13.5%) and BI-RADS category 4-5 (8/29; 27.6%). The absence of residual microcalcification after biopsy was associated with decreased risk for malignancy (15/16[93.7%]; p = 0.0297). Lesion size > 10 mm (OR = 9.3832; 95%; p = 0.0398) and BI-RADS category 4-5 (OR = 12.6004; 95%; p = 0.0006) were found to be independent predictors of upgrade to malignancy.
CONCLUSIONS: B3a lesions are associated with low risk of malignancy at excision. Lesion size > 10 mm and BI-RADS 4-5 category may represent useful predictors of upgrade to malignancy.
引用
- Bednarova I, Londero V, Linda A, et al. Do clinical and radiologic features help predict malignancy of B3 breast lesions without epithelial atypia (B3a)? Radiol Med. 2018. PMID: 29974332. doi:10.1007/s11547-018-0914-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。